StonvexLoading…
StonvexStonvexStonvexCore line items from DCOM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $123.36M | $5.73M | $19.91M | $14.49M | $9.29M |
Operating Income | Not available | $48.53M | $156.80M | $108.97M | $68.88M |
Net Income | Not available | $34.58M | $110.68M | $78.83M | $29.70M |
EPS (Diluted) | $0.80 | $0.75 | $2.36 | $1.67 | $1.09 |
Total Assets | Not available | $15.00B | $15.34B | $14.54B | $14.21B |
Total Liabilities | Not available | $13.50B | $13.87B | $13.09B | $12.78B |
Cash & Equivalents | Not available | $2.06B | $2.35B | $1.72B | $1.16B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $137.04M | $85.81M |
Shares Outstanding | Not available | 44.06M | 43.86M | 43.89M | 43.89M |